Luma Vision

LUMA Vision is a medical device company developing the VERAFEYE system, an innovative ultrasound-based cardiac imaging catheter that generates a 360-degree orbital view of all cardiac structures with an unprecedented field of view. The platform integrates hardware, software, and machine learning to deliver real-time personalized patient therapy through advanced 4D digital imaging and navigation for intracardiac procedures. Founded in 2017 as a spinoff of BioInnovate Ireland and Trinity College Dublin, the company received FDA clearance for its VERAFEYE system in April 2025. LUMA Vision serves interventional cardiologists and electrophysiologists seeking to advance decision-making accuracy in complex cardiac procedures.